Sequential HBV treatment with tenofovir alafenamide for patients with chronic hepatitis B: week 96 results from a real-world, multicenter cohort study

被引：0
作者：
Eiichi Ogawa
Makoto Nakamuta
Toshimasa Koyanagi
Aritsune Ooho
Norihiro Furusyo
Eiji Kajiwara
Kazufumi Dohmen
Akira Kawano
Takeaki Satoh
Kazuhiro Takahashi
Koichi Azuma
Nobuyuki Yamashita
Naoki Yamashita
Rie Sugimoto
Hiromasa Amagase
Masami Kuniyoshi
Yasunori Ichiki
Chie Morita
Masaki Kato
Shinji Shimoda
Hideyuki Nomura
Jun Hayashi
机构：
[1] Kyushu University Hospital,Department of General Internal Medicine
[2] National Hospital Organization,Department of Gastroenterology, Kyushu Medical Center
[3] Fukuoka City Hospital,Department of Medicine
[4] Steel Memorial Yawata Hospital,Department of Hepatology
[5] Taihaku Avenue Clinic,General Internal Medicine
[6] Kajiwara Clinic,Department of Internal Medicine
[7] Chihaya Hospital,Department of Medicine
[8] Kitakyushu Municipal Medical Center,Center for Liver Disease
[9] Kokura Medical Center,Department of Medicine
[10] National Hospital Organization,Department of Medicine
[11] Hamanomachi Hospital,The Center for Liver Disease
[12] Kyushu Central Hospital,Department of Gastroenterology
[13] Shin-Kokura Hospital,Department of Gastroenterology
[14] Kyushu Cancer Center,Department of Internal Medicine
[15] Amagase Clinic,Department of Internal Medicine
[16] Kyushu Rosai Hospital,Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences
[17] JCHO Kyushu Hospital,Graduate School of Nutritional Sciences
[18] Kyushu Railway Memorial Hospital,Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences
[19] Kyushu University,Department of Internal Medicine
[20] Nakamura Gakuen University,Kyushu General Internal Medicine Center
[21] Kyushu University,undefined
[22] Haradoi Hospital,undefined
[23] Haradoi Hospital,undefined
来源：
Hepatology International | 2022年 / 16卷
关键词：
Hepatitis B virus; Tenofovir alafenamide; Entecavir; Tenofovir disoproxil fumarate; Sequential therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：282 / 293
页数：11
相关论文
共 196 条
  • [1] Lozano R(2012)Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2095-2128
  • [2] Naghavi M(2015)Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013 Lancet 386 1546-1555
  • [3] Foreman K(2018)Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance Hepatology 67 1560-1599
  • [4] Lim S(2017)EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection J Hepatol 67 370-398
  • [5] Shibuya K(2016)Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update Hepatol Int 10 1-98
  • [6] Aboyans V(2017)Hepatitis B cure: from discovery to regulatory approval J Hepatol 67 847-861
  • [7] Schweitzer A(2019)EASL-AASLD HBV treatment endpoints conference faculty. Guidance for design and endpoints of clinical trials in chronic hepatitis B—report from the 2019 EASL-AASLD HBV treatment endpoints conference J Hepatol 2020 539-557
  • [8] Horn J(2017)Tenofovir alafenamide in the treatment of chronic hepatitis B: design, development, and place in therapy Drug Des Devel Ther 11 3197-3204
  • [9] Mikolajczyk RT(2016)Antiviral therapy for chronic hepatitis B viral infection in adults: a systematic review and meta-analysis Hepatology 63 284-306
  • [10] Krause G(2010)Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses Gastroenterology 139 1218-1229
12345678910